Dl. Galinis et al., HIV-INHIBITORY NATURAL-PRODUCTS .30. STRUCTURE-ACTIVITY MODIFICATIONSOF THE HIV-1 INHIBITORS (-CALANOLIDE-A AND (-)-CALANOLIDE-B()), Journal of medicinal chemistry, 39(22), 1996, pp. 4507-4510
The Delta(7,8) olefinic linkages within (+)-calanolide A (1) and (-)-c
alanolide B (2) were catalytically reduced to determine impact on the
anti-HIV activity of the parent compounds. In addition, a series of st
ructure modifications of the C-12 hydroxyl group in (-)-calanolide B w
as made to investigate the importance of that substituent to the HIV-1
inhibitory activity of these coumarins. A total of 14 analogs were is
olated or prepared and compared to (+)-calanolide A and (-)-calanolide
B in the NCI primary anti-HIV assay. While none of the compounds show
ed activity superior to the two unmodified leads, some structure-activ
ity requirements were apparent from the relative anti-HIV potencies of
the various analogs.